Pillstats
Rx only · Injection, Solution · Subcutaneous

Semaglutide

Brands: Ozempic · Wegovy · Semaglutide

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US21 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers2 labelers
Packages15
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 9 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$162.77$325.54$488.31$651.09Dec 2025Mar 2026Jul 2026
$473.652
Latest avg · Jul 22, 2026
-16%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

905K1.8M2.7M3.6M2025 Q12025 Q22025 Q32025 Q42026 Q1
2.2M
Rx · 2026 Q1
6.5M
Units dispensed
-19%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Novo Nordiskunknown12SUPPLYING
A-S Medication Solutionsunknown3SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Dec 19, 2025
    RECALLRecall (Class II): Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880…

    Presence of Particulate Matter: Hair was found in a prefilled syringe — Recalling firm: Novo Nordisk Inc. — Nationwide within the United States.

  • Dec 19, 2025
    RECALLRecall (Class II): Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 B…

    Presence of Particulate Matter: Hair was found in a prefilled syringe — Recalling firm: Novo Nordisk Inc. — Nationwide within the United States.

  • Apr 9, 2025
    RECALLRecall (Class II): Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx …

    Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately released. — Recalling firm: Cardinal Health Inc. — NC, SC, VA

  • Mar 22, 2021
    RECALLRecall (Class II): OZEMPIC (semaglutide) injection, 2 mg/1.5 mL (1.34 mg/mL) Prefilled pen, 1 pen, Sample. Not for Resale, Rx only, Novo N…

    Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors. — Recalling firm: Novo Nordisk Inc — Nationwide in the USA